Helen Siaw

Helen Siaw is a seasoned professional with a diverse background in the biotechnology and venture capital sectors. Currently serving as a Senior Associate at Aditum Bio since September 2024, Siaw previously held the position of Chief Business Officer at Epiodyne from July 2023 to August 2024. Siaw's experience at Mission BioCapital includes roles as an Associate and Analyst from February 2021 to August 2024, where Siaw contributed to early-stage venture initiatives. In addition, Siaw served as an Entrepreneur Success Partner at MBC BioLabs and as Head of Operations for an RNA-focused startup under Mission BioCapital from November 2022 to July 2024. Siaw's academic credentials include a PhD in Chemistry from Emory University, where research focused on protein folding dynamics and lipid interactions, complemented by a Bachelor's degree in Biochemistry and Chemistry from the University of Washington.